Robert Honigberg, MD
Robert Honigberg, MD, MBA joined Caladrius Biosciences as the Interim Chief Medical Officer in November of 2020. Dr. Honigberg is trained as a surgeon and graduated from Duke University with a BA in Economics, obtained his medical degree from Northwestern University’s Feinberg School of Medicine, and later an MBA from Northwestern University’s Kellogg School of Management. He undertook his surgical internship and residency at Albert Einstein College of Medicine/Montefiore Medical Center in New York City.
Dr. Honigberg has over 30 years of clinical and medical leadership experience in pharmaceutical, device, digital and diagnostic companies. He has held Chief Medical Officer positions at GE Healthcare, Liposcience, and Ethicon Endo-Surgery at Johnson & Johnson. He has also held positions of medical leadership in clinical development, business development and medical affairs at Schering-Plough Oncology, Ortho Biotech, CardioDx, Flexion Therapeutics, Baxalta and Shire PLC. Robert also is a former Adjunct Professor of Health Enterprise Management at Kellogg Business School/Northwestern University. He also consults for MS&T Consulting and SSI Strategy.